logo

For the Inventor, By the Inventor

Okinawa, Japan

Tatsuo Higa

This inventor holds 20 USPTO granted patents, primarily in Antitumor Compounds. Top assignees: Harbor Branch Oceanographic Institute, Kirin Beer Kabushiki Kaisha, Pharma Mar, S.a.. Active years: 1987-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tatsuo Higa. Retrieved from https://idiyas.com/inventor/tatsuo-higa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 20

% Patents Active = 90.0

Average Co-Inventor Count = 2.6

ph-index = 5

Forward Citations = 169(Granted Patents)


Location History:

  • Okinawa, FL (US) (1990)
  • Naha, JP (1989 - 1999)
  • Onzonilla, ES (2002)
  • Okinawa, JP (1987 - 2005)

Company Filing History:

goldMedal15 out of 92 
 
Harbor Branch Oceanographic Institute
 patents
silverMedal2 out of 215 
 
Kirin Beer Kabushiki Kaisha
 patents
bronzeMedal2 out of 95 
 
Pharma Mar, S.a.
 patents
4. 1 out of 8 
 
Instituto Biomar, S.a.
 patents

Years Active: 1987-2005

Loading Chart...
Areas of Expertise:
Antitumor
Cytotoxic
Guanidine Derivatives
Sphingoglycolipid
Chamigrene Derivatives
Cyclohexadienone
Alkaloids
Compositions
Macrolides
Therapeutic Uses
Tetrahydrofuryl Derivatives
20 patents (USPTO):Explore Patents
1. 6864283 - Oxy-and amino-substituted tetrahydrofuryl derivatives with antitumour activity (2005-03-08),
2. 6391900 - Cytotoxic tris(oxazole)-containing macrolides (2002-05-21),
3. 5936076 - .alpha.galactosylceramide derivatives (1999-08-10),
4. 5780441 - Sphingoglycolipid compounds and therapeutic uses thereof (1998-07-14),
5. 5449684 - Cytotoxic compounds (1995-09-12),
6. 4942180 - Antitumor chamigrene derivatives and their methods of use (1990-07-17),
7. 4921873 - Antiviral and antitumor cyclohexadienone compositions (1990-05-01),
8. 4902716 - Anti-viral chamigrene derivatives (1990-02-20),
9. 4895854 - Antitumor alkaloids (1990-01-23),
10. 4895853 - Antitumor alkaloids (1990-01-23),
11. 4895852 - Antitumor alkaloids (1990-01-23),
12. 4882445 - Antitumor cyclohexanone compositions and derivatives thereof (1989-11-21),
13. 4859782 - Misakinolide compositions and their derivatives (1989-08-22),
14. 4851441 - Antiviral guanidine derivatives compositions and their methods of use (1989-07-25),
15. 4808590 - Antiviral, antitumor and antifungal compositions and their methods of use (1989-02-28),

Title: The Innovative Contributions of Tatsuo Higa

Introduction: Tatsuo Higa, an accomplished inventor based in Okinawa, Japan, has made significant strides in the field of pharmaceutical innovations. With a notable portfolio comprising 20 patents, his work focuses primarily on antitumor compounds that have the potential to revolutionize cancer treatment.

Latest Patents: One of Higa's latest patents is for oxy- and amino-substituted tetrahydrofuryl derivatives with antitumor activity. This patent features a complex formula that includes a variety of chemical groups designed to enhance the efficacy of these compounds in targeting cancer cells. The patent outlines various compounds where R and R' can be selected from different groups including substituted or unsubstituted aliphatic and aromatic units, offering a diverse toolkit for future drug development.

Career Highlights: Higa has had an impressive career, making substantial contributions to the field of medicinal chemistry. He has worked with notable institutions such as Harbor Branch Oceanographic Institution, Inc. and Kirin Beer Kabushiki Kaisha, gaining valuable experience that informs his inventive processes. His extensive research and development efforts have culminated in a robust number of patents that underscore his reputation as a leading inventor.

Collaborations: Throughout his career, Tatsuo Higa has collaborated with esteemed colleagues, including Ryuichi Sakai and Shinichi Sakemi. These collaborations have undoubtedly played a role in enhancing his innovative capabilities and expanding the applications of his research findings.

Conclusion: Tatsuo Higa stands out as a prominent inventor whose work continues to push the boundaries of pharmaceutical advancements. His dedication to developing antitumor compounds not only reflects his ingenuity but also contributes significantly to the ongoing fight against cancer. The breadth of his patents illustrates the profound impact of his work on medicine, and his collaborations underscore the importance of teamwork in fostering innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…